The Center for Medicare and Medicaid Service’s decision to automatically provide Medicare add-on payments for existing and future hospital drugs to treat COVID-19 demonstrates the agency’s recognition that supplemental reimbursement is crucial for ensuring access to new treatments.
The policy is announced in an interim final rule released on 28 October that also addresses Medicare reimbursement for...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?